Table 3.

Results of stratified analysis, reporting log2 Fold Change values and P-values.

	miR-99b-3p		miR-197-3p		miR-374b-5p
	log2 Fold Change	P	log2 Fold Change	P	log2 Fold Change	P
CD vs control	-0.884	0.0343	-0.881	0.0132	0.051	0.3991
LI vs control	-0.175	0.2993	-0.510	0.3089	0.463	0.1217
patient vs control	-0.808	0.0471	-0.819	0.0326	0.276	0.3943
CD-LI vs control	-0.842	0.1555	-1.198	0.0196	0.438	0.3761
CD+LI vs control	-0.932	0.0264	-0.849	0.0427	-0.683	0.2380
CD-TI vs control	-0.811	0.0801	-0.842	0.0323	-0.056	0.3722
CD+TI vs control	-1.548	0.0363	-1.311	0.0254	-1.015	0.1610
CD-DH vs control	-0.986	0.0222	-0.868	0.0152	-0.022	0.2690
CD+DH vs control	-0.311	0.4169	-1.123	0.1309	1.523	0.1828
CD vs LI	0.710	0.0790	0.364	0.0954	0.411	0.0743
CD-LI vs LI	-0.664	0.2695	-0.680	0.0852	-0.025	0.2494
CD+LI vs LI	-0.333	0.0487	-0.561	0.1773	-1.146	0.0384
CD-TI vs LI	0.633	0.1270	0.332	0.1627	0.194	0.1459
CD+TI vs LI	1.373	0.0706	0.800	0.0815	1.153	0.0529
CD-DH vs LI	1.751	0.0521	0.356	0.1009	0.485	0.0402
CD+DH vs LI	0.808	0.500	0.611	0.2304	-1.062	0.3605
CD+LI vs CD-LI	-0.092	0.3195	0.347	0.2509	0.463	0.1217
CD+TI vs CD-TI	-0.737	0.0994	-0.468	0.2612	-0.960	0.2232
CD+DH vs CD-DH	0.674	0.1047	-0.255	0.4283	1.545	0.0940

vs – versus, CD – celiac disease, LI – lactose intolerance, TI – thyroid impairment, DH – dermatitis herpetiformis. In bold – P-values lower than 0.05.